Congenital Generalized Lipodystrophy
Symptoms, Doctors, Treatments, Advances & More

Congenital Generalized Lipodystrophy Overview

Save information for later
Sign Up

Learn About Congenital Generalized Lipodystrophy

Condition 101 content is not available at this time, but we are continually updating the site. Please check back.

However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.

Who are the top Congenital Generalized Lipodystrophy Local Doctors?
Elite in Congenital Generalized Lipodystrophy
Endocrinology | Internal Medicine
Elite in Congenital Generalized Lipodystrophy
Endocrinology | Internal Medicine

Domino's Farms

24 Frank Lloyd Wright Dr Ste 1300, Lobby C, 
Ann Arbor, MI 
Languages Spoken:
English
Offers Telehealth

Dr. Elif Oral is a professor in the Division of Metabolism, Endocrinology and Diabetes (MEND) at the University of Michigan. She completed her medical education in her home country of Turkey at the University of Istanbul. In 1996, she completed her residency in Internal Medicine at Sinai Hospital Detroit (Michigan). She then completed a fellowship in Endocrinology, Metabolism and Diabetes at the National Institute of Health, where she also chose to stay as a Senior Fellow under the mentorship of Drs SimeonTaylor and Phillip Gorden in in the Diabetes Branch of NIDDK.Since joining the University of Michigan in 2002 as an Assistant Professor of Medicine, along with her regular faculty responsibilities, Dr. Oral also completed a Masters of Science Degree in Clinical Research Design and Biostatistics at the School of Public Health. Her clinical interests are in insulin resistance, obesity, lipid disorders, and diabetes.Dr Oral's research focuses on the importance of adipocytes in human metabolism and adipocyte hormones such as leptin. She is best known for her work showing the remarkable efficacy of leptin in rare lipodystrophy syndromes. Metreleptin received approval by the FDA (2014) and EMA (2016) as a treatment for lipodystrophy owing to a large part to her original vision and work. These studies provided the basis for her current work with three big goals: identification of novel metabolic diseases, discovery of new disease mechanisms and finding treatments for patients afflicted with these disorders. In addition to her roles as physician, educator, and researcher, Dr Oral is also the director of two programs at MEND: Atypical Diabetes Program and Obesity and Metabolic Disorders Program. She directed the Post-Bariatric Surgery Care Program from 2012 to 2021 and continues to conduct research on the cohort of patients who had bariatric surgery performed in the Michigan Bariatric Surgery program. Dr. Oral is rated as an Elite provider by MediFind in the treatment of Congenital Generalized Lipodystrophy. She is also highly rated in 16 other conditions, according to our data. Her clinical expertise encompasses Familial Partial Lipodystrophy, Congenital Generalized Lipodystrophy, Familial Hypertriglyceridemia, Gastric Bypass, and Sleeve Gastrectomy. Dr. Oral is board certified in Endocrinology, Diabetes & Metabolism.

Elite in Congenital Generalized Lipodystrophy
Endocrinology
Elite in Congenital Generalized Lipodystrophy
Endocrinology

University Of Texas Southwestern Medical Center

5323 Harry Hines Blvd, 
Dallas, TX 
Languages Spoken:
English

Abhimanyu Garg is an Endocrinologist practicing medicine in Dallas, Texas. Dr. Garg is rated as an Elite provider by MediFind in the treatment of Congenital Generalized Lipodystrophy. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Acrorenal Mandibular Syndrome, Familial Partial Lipodystrophy, Congenital Generalized Lipodystrophy, Familial Hypertriglyceridemia, and Gastric Bypass.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Congenital Generalized Lipodystrophy
Elite in Congenital Generalized Lipodystrophy
Dokuz Eylul, TR 

Baris Akinci practices practicing medicine in Dokuz Eylul, Turkey. Mr. Akinci is rated as an Elite expert by MediFind in the treatment of Congenital Generalized Lipodystrophy. He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Familial Partial Lipodystrophy, Congenital Generalized Lipodystrophy, Familial Hypertriglyceridemia, and Gigantism.

What are the latest Congenital Generalized Lipodystrophy Clinical Trials?
A Two-Part, Randomized, Placebo-Controlled Phase 3 Study of the Efficacy, Safety, and Pharmacokinetics of Mibavademab in Patients With Generalized Lipodystrophy (LAGO)

Summary: This study is researching a new drug called mibavademab (called study drug). The study involves participants with a condition called Generalized Lipodystrophy (GLD). The aim of the study is to see how well mibavademab works and what side effects it has. Researchers will also look at how much mibavademab is in the body at different times. This is a 2-part study: Part A is an efficacy study in pedia...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Open-label, Phase 3b Study to Evaluate Effectiveness, Safety and Pharmacokinetic Parameters of Metreleptin in Patients Under 6 Years of Age With Generalised Lipodystrophy and Associated Diabetes Mellitus and/or Hypertriglyceridaemia

Summary: This is an open-label, Phase 3b study to evaluate effectiveness, safety and pharmacokinetic parameters of metreleptin in patients under 6 years of age with generalised lipodystrophy and associated diabetes mellitus and/or hypertriglyceridaemia